School of medical technology and information engineering, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
FUDAN University, school of basic medical sciences, Shanghai, 200433, PR China.
BMC Pharmacol Toxicol. 2022 May 7;23(1):29. doi: 10.1186/s40360-022-00568-4.
Thioacetamide (TAA) is used in various fields, such as synthetic drugs, organic chemical synthesis, and materials chemistry. TAA is mainly used to establish animal liver injury models and other organ damage models to explore their mechanisms for helping patients with liver disease. Liver damage can lead to abnormal expression of some enzymes in the serum, so we detected the appropriate enzyme levels in the serum of SD rats to verify the damage of TAA to the liver. More importantly, TAA caused bone damage is barely understood. Therefore, our research aims to establish a rat model reflecting the acute bone damage injury caused by TAA.
The SD rats were intraperitoneally injected with normal saline (0.9%) or TAA (200 mg/kg, 400 mg/kg) for 1 month (once the other day). After the last intraperitoneal injection, serum samples from rats were used for biochemical tests. Masson staining is used to detect liver damage, and micro-CT is used to detect the changes in bone. Moreover, the three-point bending experiment was used to detect the force range of the hind limbs of SD rats.
Compared with the control group, after the intraperitoneal injection of TAA, the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), uric acid (UA), total bile acid (TBA), alkaline phosphatase (ALP), carbamide (UREA) and creatinine (CREA) rose sharply, while the levels of serum content of total protein (TP), lactate dehydrogenase (LDH), calcium (Ca) and phosphorus (P) were severely reduced. After TAA administration, collagen fibers were deposited and liver fibrosis was obvious. Micro-CT results showed that the bone surface, tissue surface, bone volume, and tissue volume of rats with an intraperitoneal injection of TAA were significantly reduced. In addition, the bones of rats with an intraperitoneal injection of TAA can resist less pressure and are prone to fractures.
TAA can cause liver damage in SD rats, which is explained by the changes in serum biochemical indicators and the deposition of liver collagen. More importantly, TAA can reduce bone mineral density and increase the separation of bone trabeculae in SD rats, and finally lead to bone injury. This suggests that TAA may become an ideal model to investigate abnormal bone metabolism after liver injury.
硫代乙酰胺(TAA)在合成药物、有机化学合成、材料化学等领域有广泛应用。TAA 主要用于建立动物肝损伤模型和其他器官损伤模型,以探索其对肝病患者的作用机制。肝损伤会导致血清中某些酶的异常表达,因此我们检测了 SD 大鼠血清中合适的酶水平,以验证 TAA 对肝脏的损伤。更重要的是,TAA 引起的骨骼损伤机制尚不清楚。因此,我们的研究旨在建立一个反映 TAA 引起的急性骨损伤的大鼠模型。
SD 大鼠连续 1 个月(隔天 1 次)经腹腔注射生理盐水(0.9%)或 TAA(200mg/kg、400mg/kg)。末次腹腔注射后,收集大鼠血清样本进行生化检测。Masson 染色用于检测肝损伤,微 CT 用于检测骨变化。此外,三点弯曲实验用于检测 SD 大鼠后肢的受力范围。
与对照组相比,TAA 腹腔注射后,天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、尿酸(UA)、总胆汁酸(TBA)、碱性磷酸酶(ALP)、尿素(UREA)和肌酐(CREA)水平急剧升高,而血清总蛋白(TP)、乳酸脱氢酶(LDH)、钙(Ca)和磷(P)水平严重降低。TAA 给药后胶原纤维沉积,肝纤维化明显。微 CT 结果显示 TAA 腹腔注射大鼠的骨表面、组织表面、骨体积和组织体积明显减少。此外,TAA 腹腔注射大鼠的骨骼承受的压力更小,更容易骨折。
TAA 可导致 SD 大鼠肝损伤,这可通过血清生化指标的变化和肝胶原的沉积来解释。更重要的是,TAA 可降低 SD 大鼠的骨密度,增加骨小梁分离,最终导致骨损伤。这表明 TAA 可能成为研究肝损伤后异常骨代谢的理想模型。